Good mental health is a key component of health-related quality of life in persons living with HIV. The live webinar on May 19th (18:00 - 21:00) ‘HIV & Mental Health 2021’ follows after the successful HIV and mental health conference organized in 2018.
During the ‘HIV & Mental Health 2021’ live webinar we will discuss the progress that has been made in the HIV mental health care path and the stepped care path that has been developed. Furthermore in this webinar, one important quality of life domain in HIV will be addressed: stigma.
After an interactive evening, recommendations will be defined on how to improve the integrated mental healthcare for persons living with HIV in the coming years.
Program
Introduction and welcome - Guido van den Berk, MD, PhD – ID physician, OLVG & prof. Arjan Bos, MD – professor in clinical psychology, Open University of The Netherlands
Online self-help for people with HIV and depressed mood: implementation challenges - Nadia Garnefski, PhD – associate professor clinical psychology, Leiden University & Vivian Kraaij, PhD – associate professor clinical psychology, Leiden University
Measuring health related quality of life though PROMs: the way forward - Guido van den Berk, MD, PhD – ID physician, OLVG
HIV, stigma & mental health - Yvonne van der Kooij – junior researcher – Open University of The Netherlands & Loek Elsenburg – nurse specialist, DCKlinieken, Amsterdam
HIV & mental health, an integrated response - Robert Remien, PhD – professor in clinical psychology, Colombia University, New York, USA
HIV mental health care path: an update and looking forward - Guido van den Berk, MD, PhD – ID physician, OLVG & Moniek Wassenaar, MD, PhD – psychiatrist, OLVG
Perspectives form an integrated care partner - Brand Coumou, PhD – psychiatrist/sexologist, GGZ InGeest
Concluding remarks & closing of the webinar - Guido van den Berk, MD, PhD – ID physician, OLVG
Accreditation
Accreditation for this webinar will be requested at the NVZA/KNMP, NIV, V&VN, VSR, NIP, NVvP
This symposium is a partnership between OLVG, OU and Gilead Sciences Netherlands BV